US prescription drug spending will top $560 billion in 2026, according to current projections. This would represent an 8.2% increase from the previous year. Growing demand for obesity and diabetes treatments is partly driving this rise. These include a new generation of GLP-1 medicines. Projections show prescription medicines outpacing all other major categories of healthcare spending in the US. Their…
Tag: Diabetes Care
-
Generic Semaglutide Pricing Could Disrupt Global Markets
New research reveals that manufacturers could sell generic versions of Novo Nordisk’s blockbuster drugs, Ozempic and Wegovy, for less than $3 a month. This study highlights a massive gap between current list prices and actual production costs. It suggests a future where powerful weight-loss treatments are accessible to billions. The Massive Gap In Generic Semaglutide Pricing Researchers at the University…